Close

Mallinckrodt (MNK) Completes Acquisition of Ocera Therapeutics (OCRX)

December 11, 2017 9:19 AM EST Send to a Friend
Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has closed the acquisition of Ocera ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login